Clinical Trials

Showing 301 - 320 of 513 trials
Titlesort icon Investigator Disease(s)
A Phase II Study of Transoral Surgical Removal of HPV-Positive Locally Advanced Oropharynx Cancer Followed by Risk-Stratified Therapy
Relapsed/Refractory
[Protocol 14-035]
Morris, Luc
  • Head & Neck Cancer
A Phase II Study of Trastuzumab Emtansine versus Trastuzumab/Paclitaxel in Women with Stage I HER2-Positive Breast Cancer
[Protocol 14-221]
Dang, Chau
  • Breast Cancer
A Phase II Study of Treatment-Free Remission in Chronic-Phase Chronic Myelogenous Leukemia Patients Who Achieve and Sustain a Complete Molecular Response After Switching to Nilotinib
[Protocol 13-152]
Berman, Ellin
  • Leukemia
    • Chronic Myelocytic Leukemia
A Phase II Study of Tretinoin plus Arsenic Trioxide in Newly Diagnosed Acute Promyelocytic Leukemia Followed by Risk-Adapted Therapy
[Protocol 11-040]
Park, Jae
  • Leukemia
    • Acute Myelogenous Leukemia
A Phase II Study of Vemurafenib in Patients with BRAF V600 Mutation-Positive Cancers
[Protocol 12-131]
Hyman, David
  • Hematology
    • Hematologic Disorders
    • Multiple Myeloma
  • Rare Blood Disorders
A Phase II Study of Vemurafenib in Patients with Relapsed or Refractory Hairy Cell Leukemia
Relapsed/Refractory
[Protocol 12-200]
Park, Jae
  • Leukemia
A Phase II Study of Vismodegib plus Radiation Therapy for Locally Advanced Basal Cell Cancers of the Head and Neck
[Protocol 14-022]
Barker, Christopher
  • Basal Cell Carcinoma
  • Head & Neck Cancer
A Phase II Study of Vorinostat for Metastatic Uveal Melanoma
[Protocol 12-027]
Carvajal, Richard
  • Melanoma
    • Melanoma of the Eye
A Phase II Study of VS-6063 in Patients with Malignant Pleural Mesothelioma
[Protocol 13-185]
Zauderer, Marjorie
  • Mesothelioma
A Phase II Study of Whole-Lung IMRT in Children and Adults with Synovial Sarcoma that Spread to the Lungs
[Protocol 14-075]
Wolden, Suzanne
  • Sarcomas
    • Soft Tissue Sarcoma
A Phase II Study of WT-1 Analog Peptide Vaccine in Patients with Malignant Pleural Mesothelioma
[Protocol 10-134]
Krug, Lee
  • Mesothelioma
A Phase II Study to See if Carvedilol Can Help Prevent Heart Function Problems in Women Receiving Anthracyclines or Anti-HER2 Therapies for Breast Cancer
[Protocol 14-099]
Yu, Anthony
  • Breast Cancer
A Phase II Trial of a WT-1 Vaccine in Patients with Acute Myeloid Leukemia
[Protocol 10-143]
Maslak, Peter
  • Leukemia
    • Acute Myelogenous Leukemia
A Phase II Trial of Chemotherapy Plus Cetuximab Followed by Surgery in Patients with Locally Advanced Thymoma
[Protocol 09-038]
Huang, James
  • Thymoma
A Phase II Trial of Everolimus and Bevacizumab in Advanced Non-Clear Cell Renal Cell Cancer
[Protocol 10-226]
Feldman, Darren
  • Kidney Cancer
A Phase II Trial of Transplants from HLA-Compatible Donors with T-cell Depleted Peripheral Blood Stem Cells Isolated by the CliniMACS System for the Treatment of Patients with Hematologic Malignancies and Disorders
[Protocol 10-050]
O'Reilly, Richard
  • Blood and Marrow Transplantation
    • Transplantation
  • Hematology
    • Multiple Myeloma
    • Myelodysplastic Syndrome
  • Leukemia
    • Chronic Myelocytic Leukemia
    • Myelodysplastic Syndrome
  • Lymphoma
    • Non-Hodgkin's Lymphoma
A Phase II/III Study of Paclitaxel/Carboplatin with and without Metformin for Treating Stage III or IV or Recurrent Endometrial Cancer
[Protocol 14-081]
Aghajanian, Carol
  • Uterine (Endometrial) Cancer
A Phase II/III Study of Surgery Followed by Radiation Therapy plus either Cisplatin, Docetaxel, or Both Drugs for High-Risk Squamous Cell Cancer of the Head and Neck
[Protocol 13-115]
Lee, Nancy
  • Head & Neck Cancer
A Phase IIA Study of BL-8040 in Patients with Recurrent or Persistent Acute Myeloid Leukemia
Relapsed/Refractory
[Protocol 13-166]
Tallman, Martin
  • Leukemia
    • Acute Myelocytic Leukemia
    • Acute Myelogenous Leukemia
A Phase IIB Study of Nivolumab Alone or with Ipilimumab in Patients with Recurrent Glioblastoma
Relapsed/Refractory
[Protocol 14-009]
Omuro, Antonio
  • Brain Tumors, Primary
    • Gliomas